Roy Winston, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), sold 4,552 shares at $61.04 ($278K) on 2021-06-04, disclosed to the SEC on 2021-06-08.
Open-market sale of $278k PCRX by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.04 | 2,276 | $139K | 50.0% |
| 2 | $61.04 | 2,276 | $139K | 50.0% |
| Total | $61.04 avg | 4,552 | $278K | 100% |
| Filing → |
| PCRX | SELL | 2022-08-05 | $27K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $1.9M | — | Filing → |
| PCRX | SELL | 2021-04-02 | $3.1M | — | Filing → |